Clinitech Laboratory Limited (BOM:544220)
India · Delayed Price · Currency is INR 35.10
-1.50 (-4.10%)
At close: Sep 1, 2026
Clinitech Laboratory Revenue
In the fiscal year ending March 31, 2026, Clinitech Laboratory had annual revenue of 94.91M INR with 15.26% growth. Clinitech Laboratory had revenue of 44.11M in the half year ending March 31, 2026, with 31.87% growth.
Revenue
94.91M
Revenue Growth
+15.26%
P/S Ratio
0.84
Revenue / Employee
585.88K
Employees
162
Market Cap
80.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 94.91M | 12.56M | 15.26% |
| Mar 31, 2025 | 82.35M | 18.32M | 28.61% |
| Mar 31, 2024 | 64.03M | 555.00K | 0.87% |
| Mar 31, 2023 | 63.48M | -368.00K | -0.58% |
| Mar 31, 2022 | 63.84M | 18.30M | 40.19% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |